News

Viking Therapeutics stock remains under pressure, but analysts said Wednesday the company's strategy for its Phase 3 studies could pay off.
The Viking 74 had a blazing act to follow in replacing the Viking 72, the fastest ride in the six-decade history of the ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinically staged biopharma incorporated in 2012 and headquartered in San Diego, ... At 72 weeks, Zepbound® reported -20.2% weight loss.
Wayfair’s 72-Hour Clearout sale began Satuday, January 11 and will last until Tuesday, January 14. ... Viking Cast Iron 10.5 Inch Chef’s Pan $199.99 (was $340) ...
Comparing Eli Lilly and Viking Therapeutics. Every market leader started somewhere, and Eli Lilly's history of innovation spans 149 years since its founding in 1876.
Viking Therapeutics announces its fourth-quarter financial results after Wednesday's closing bell. ... Viking Therapeutics shares are down 8.72% after hours at $30.58 on Wednesday. ...